{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:49:07Z","timestamp":1790740147446,"version":"4.1.0"},"reference-count":105,"publisher":"JLE","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.nephro.2019.05.001","type":"journal-article","created":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T06:02:53Z","timestamp":1558764173000},"page":"242-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Complications et prises en charge th\u00e9rapeutiques des anomalies du m\u00e9tabolisme phosphocalcique de l\u2019insuffisance r\u00e9nale chronique"],"prefix":"10.1684","volume":"15","author":[{"given":"Guillaume","family":"Jean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Chazot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2019.05.001_bib0530","first-page":"S1","article-title":"Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"113","author":"KDIGO","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0535","doi-asserted-by":"crossref","first-page":"167984","DOI":"10.4061\/2010\/167984","article-title":"Relationship between fibroblast growth factor-23\u00a0and mineral metabolism in chronic kidney disease","volume":"2010","author":"Nitta","year":"2010","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.nephro.2019.05.001_bib0540","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2215\/CJN.08680811","article-title":"Combined use of vitamin D status and FGF23\u00a0for risk stratification of renal outcome","volume":"7","author":"Nakano","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2019.05.001_bib0545","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1111\/j.1523-1755.2005.09501.x","article-title":"Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease","volume":"95","author":"Silver","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0550","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1755.2000.00178.x","article-title":"Increased risk of hip fracture among patients with end-stage renal disease","volume":"58","author":"Alem","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0555","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"5\u00a0Suppl. 3","key":"10.1016\/j.nephro.2019.05.001_bib0560","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2019.05.001_bib0565","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1046\/j.1523-1755.1998.00154.x","article-title":"Long-term evolution of cardiomyopathy in dialysis patients","volume":"54","author":"Foley","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0570","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease\u00a0: impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2019.05.001_bib0575","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ndt\/gfn571","article-title":"Peripheral vascular calcification in long-haemodialysis patients\u00a0: associated factors and survival consequences","volume":"24","author":"Jean","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2019.05.001_bib0580","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","article-title":"Arterial calcifications and bone histomorphometry in end-stage renal disease","volume":"15","author":"London","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"4\u00a0Suppl 3","key":"10.1016\/j.nephro.2019.05.001_bib0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"Bone metabolism and disease in chronic kidney disease","volume":"42","author":"Eknoyan","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2019.05.001_bib0590","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.lpm.2011.04.019","article-title":"Comment je traite les troubles phosphocalciques en cas d\u2019insuffisance r\u00e9nale chronique","volume":"40","author":"Jean","year":"2011","journal-title":"Presse Med"},{"key":"10.1016\/j.nephro.2019.05.001_bib0595","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","article-title":"A novel mechanism for skeletal resistance in uremia","volume":"58","author":"Slatopolsky","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0600","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2009.374","article-title":"Parathyroid hormone measurement in CKD","volume":"77","author":"Souberbielle","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0605","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/ndt\/gfm849","article-title":"Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients\u00a0: the CHOICE study","volume":"23","author":"Melamed","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2019.05.001_bib0610","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.ki.5001606","article-title":"Inter-method variability in PTH measurement\u00a0: implication for the care of CKD patients","volume":"70","author":"Souberbielle","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0615","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0272-6386(95)90599-5","article-title":"Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis","volume":"26","author":"Qi","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2019.05.001_bib0620","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5002769","article-title":"K\/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients","volume":"73","author":"Barreto","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0625","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH\u00a0: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2019.05.001_bib0630","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0635","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.nephro.2012.04.003","article-title":"Que faire de ces valeurs d\u2019hormones parathyro\u00efdiennes r\u00e9put\u00e9es trop basses chez les patients dialys\u00e9s\u00a0?","volume":"8","author":"Jean","year":"2012","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2019.05.001_bib0640","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nephro.2011.05.002","article-title":"Les formes cliniques et biologiques de l\u2019hyperparathyro\u00efdie secondaire en dialyse","volume":"8","author":"Jean","year":"2012","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2019.05.001_bib0645","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1681\/ASN.2008020159","article-title":"Timing of onset of CKD-related metabolic complications","volume":"20","author":"Moranne","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2019.05.001_bib0650","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.2215\/CJN.02680310","article-title":"Reciprocal control of 1,25-dihydroxyvitamin\u00a0D and FGF23\u00a0formation involving the FGF23\/Klotho system","volume":"5","author":"Pri\u00e9","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl. 1","key":"10.1016\/j.nephro.2019.05.001_bib0655","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1755-6686.2009.00050.x","article-title":"Pathogenesis of bone and mineral related disorders in chronic kidney disease\u00a0: key role of hyperphosphatemia","volume":"35","author":"Roman-Garcia","year":"2009","journal-title":"J Ren Care"},{"key":"10.1016\/j.nephro.2019.05.001_bib0660","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0272-6386(95)90541-3","article-title":"Secondary hyperparathyroidism in renal failure\u00a0: the trade-off hypothesis revisited","volume":"25","author":"Llach","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2019.05.001_bib0665","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1046\/j.1523-1755.1998.00875.x","article-title":"Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis","volume":"53","author":"Mucsi","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0670","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1053\/j.ajkd.2005.05.025","article-title":"Relationship of phosphorus and calcium-phosphorus product with mortality in CKD","volume":"46","author":"Menon","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2019.05.001_bib0675","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.2215\/CJN.12761211","article-title":"25-hydroxyvitamin\u00a0D response to cholecalciferol supplementation in hemodialysis","volume":"7","author":"Armas","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2019.05.001_bib0680","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1681\/ASN.2007040449","article-title":"Pitfalls of measuring total blood calcium in patients with CKD","volume":"19","author":"Gauci","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2019.05.001_bib0685","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin\u00a0D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2019.05.001_bib0690","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1359\/jbmr.080608","article-title":"Serum vitamin\u00a0D measurement may not reflect what you give to your patients","volume":"23","author":"Cavalier","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.nephro.2019.05.001_bib0695","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1210\/jcem-63-4-954","article-title":"Assessment of the free fraction of 25-hydroxyvitamin\u00a0D in serum and its regulation by albumin and the vitamin\u00a0D-binding protein","volume":"63","author":"Bikle","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nephro.2019.05.001_bib0700","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ajcn\/84.1.18","article-title":"Estimation of optimal serum concentrations of 25-hydroxyvitamin\u00a0D for multiple health outcomes","volume":"84","author":"Bischoff-Ferrari","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nephro.2019.05.001_bib0705","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/ki.1987.295","article-title":"Vitamin\u00a0D and the kidney","volume":"32","author":"Holick","year":"1987","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0710","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/j.jrn.2008.04.003","article-title":"Vitamin\u00a0D deficiency and associated factors in hemodialysis patients","volume":"18","author":"Jean","year":"2008","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.nephro.2019.05.001_bib0715","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ki.2008.501","article-title":"Vitamin\u00a0D levels and patient outcome in chronic kidney disease","volume":"75","author":"Ravani","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0720","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1093\/ndt\/gfq650","article-title":"Vascular calcification and 25-hydroxyvitamin\u00a0D levels in non-dialysis patients with chronic kidney disease stages\u00a04\u00a0and\u00a05","volume":"26","author":"Garcia-Canton","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2019.05.001_bib0725","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1681\/ASN.2006060573","article-title":"Mineral metabolism and arterial functions in end-stage renal disease\u00a0: potential role of 25-hydroxyvitamin\u00a0D deficiency","volume":"18","author":"London","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2019.05.001_bib0730","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ajkd.2005.09.024","article-title":"PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis","volume":"47","author":"Danese","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2019.05.001_bib0735","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1523-1755.2004.00895.x","article-title":"Vascular calcification\u00a0: a stiff challenge for the nephrologist\u00a0: does preventing bone disease cause arterial disease\u00a0?","volume":"66","author":"Goldsmith","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0740","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/ndt\/gfq491","article-title":"The link between bone and coronary calcifications in CKD-5\u00a0patients on haemodialysis","volume":"26","author":"Asci","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2019.05.001_bib0745","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1046\/j.1523-1755.1999.00461.x","article-title":"Circulating biochemical markers of bone remodeling in uremic patients","volume":"55","author":"Urena","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0750","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","article-title":"Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients","volume":"7","author":"Urena","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2019.05.001_bib0755","first-page":"1046","article-title":"Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease","volume":"77","author":"Garnero","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nephro.2019.05.001_bib0760","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.clinbiochem.2012.01.018","article-title":"Total and bone-specific alkaline phosphatases in haemodialysis patients with chronic liver disease","volume":"45","author":"Jean","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1016\/j.nephro.2019.05.001_bib0765","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00198-004-1712-4","article-title":"Serum levels of C-terminal telopeptide of type\u00a0I collagen\u00a0: a useful new marker of cortical bone loss in hemodialysis patients","volume":"16","author":"Okuno","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0770","doi-asserted-by":"crossref","first-page":"c112","DOI":"10.1159\/000081552","article-title":"Evaluation of serum beta-carboxy-terminal cross-linking telopeptide of type\u00a0I collagen as marker of bone resorption in chronic hemodialysis patients","volume":"98","author":"Reichel","year":"2004","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.nephro.2019.05.001_bib0775","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00467-006-0378-x","article-title":"Effect of haemodialysis on markers of bone turnover in children","volume":"22","author":"Waller","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nephro.2019.05.001_bib0780","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","article-title":"Renal osteodystrophy in the first decade of the new millennium\u00a0: analysis of 630\u00a0bone biopsies in black and white patients","volume":"26","author":"Malluche","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.nephro.2019.05.001_bib0785","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy\u00a0: a position statement from kidney disease\u00a0: improving global outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0790","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/sj.ki.5000311","article-title":"Osteoporosis in hemodialysis patients revisited by bone histomorphometry\u00a0: a new insight into an old problem","volume":"69","author":"Barreto","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0795","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1093\/ndt\/gfn403","article-title":"Abdominal aortic calcification in dialysis patients\u00a0: results of the CORD study","volume":"23","author":"Honkanen","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"1\u00a0Suppl\u00a02","key":"10.1016\/j.nephro.2019.05.001_bib0800","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1053\/ajkd.2001.20745","article-title":"Imaging of cardiovascular calcifications with electron beam tomography in hemodialysis patients","volume":"37","author":"Raggi","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2019.05.001_bib0805","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s001980050280","article-title":"Do we need to change the WHO definition of osteoporosis?","volume":"11","author":"Delmas","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0810","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ki.2008.264","article-title":"Chronic kidney disease and bone fracture: a growing concern","volume":"74","author":"Nickolas","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0815","first-page":"57","article-title":"Fractures and vertebral bone mineral density in patients with renal osteodystrophy","volume":"30","author":"Piraino","year":"1988","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2019.05.001_bib0820","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00198-009-0988-9","article-title":"Femoral bone mineral density reflects histologically determined cortical bone volume in hemodialysis patients","volume":"21","author":"Adragao","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0825","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1681\/ASN.2010121253","article-title":"Differences in bone quality in low- and high-turnover renal osteodystrophy","volume":"23","author":"Malluche","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2019.05.001_bib0830","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ndt\/gfn466","article-title":"Vascular calcifications, vertebral fractures and mortality in haemodialysis patients","volume":"24","author":"Rodriguez-Garcia","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2019.05.001_bib0835","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1001\/jama.288.23.3014","article-title":"Risk of hip fracture among dialysis and renal transplant recipients","volume":"288","author":"Ball","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2019.05.001_bib0840","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJMcp042092","article-title":"Clinical practice. Screening for osteoporosis","volume":"353","author":"Raisz","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2019.05.001_bib0845","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.108.783738","article-title":"Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis","volume":"118","author":"Shroff","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.nephro.2019.05.001_bib0850","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ndt\/15.7.1014","article-title":"Arterial stiffening and vascular calcifications in end-stage renal disease","volume":"15","author":"Gu\u00e9rin","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2019.05.001_bib0855","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.CIR.103.7.987","article-title":"Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure","volume":"103","author":"Gu\u00e9rin","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.nephro.2019.05.001_bib0860","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1161\/01.CIR.103.11.1529","article-title":"Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality","volume":"103","author":"Wilson","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.nephro.2019.05.001_bib0865","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/01.ATV.0000198390.34524.ba","article-title":"Quantification of abdominal aortic calcification on CT","volume":"26","author":"Jayalath","year":"2006","journal-title":"Arterioscler Thrombo Vasc Biol"},{"key":"10.1016\/j.nephro.2019.05.001_bib0870","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.nephro.2010.04.003","article-title":"La calciphylaxie chez le patient dialys\u00e9: la reconna\u00eetre pour la traiter aussit\u00f4t que possible","volume":"6","author":"Jean","year":"2010","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2019.05.001_bib0875","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/ndt\/gfs119","article-title":"Biological impact of targeted dialysate calcium changes in haemodialysis patients: the key role of parathyroid hormone","volume":"28","author":"Jean","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2019.05.001_bib0880","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nephro.2012.08.003","article-title":"Les concentrations \u00e9lev\u00e9es du calcium du dialysat ne sont pas associ\u00e9es \u00e0 la mortalit\u00e9 chez les patients h\u00e9modialys\u00e9s: les r\u00e9sultats de l\u2019\u00e9tude ARNOS","volume":"9","author":"Jean","year":"2013","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2019.05.001_bib0885","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","article-title":"Phosphorus binders and survival on hemodialysis","volume":"20","author":"Isakova","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2019.05.001_bib0890","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMra0912522","article-title":"Oral phosphate binders in patients with kidney failure","volume":"362","author":"Tonelli","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2019.05.001_bib0895","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1053\/j.ajkd.2009.06.004","article-title":"Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials","volume":"54","author":"Sankar","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2019.05.001_bib0900","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJM198404263101704","article-title":"Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis","volume":"310","author":"Andreoli","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2019.05.001_bib0905","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000181985","article-title":"Dialysis osteomalacia and aluminum intoxication","volume":"26","author":"Drueke","year":"1980","journal-title":"Nephron"},{"key":"10.1016\/j.nephro.2019.05.001_bib0910","first-page":"6","article-title":"Control of predialytic hyperphosphatemia by oral calcium acetate and calcium carbonate","volume":"60","author":"Morini\u00e8re","year":"1992","journal-title":"Comparable efficacy for half the dose of elemental calcium given as acetate without lower incidence of hypercalcemia. Nephron"},{"key":"10.1016\/j.nephro.2019.05.001_bib0915","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0920","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/j.ajkd.2008.07.043","article-title":"Progression of calcification in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study","volume":"52","author":"Qunibi","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2019.05.001_bib0925","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1111\/j.1523-1755.2005.00753.x","article-title":"Progressive accumulation of lanthanum in the liver of normal and uremic rats","volume":"68","author":"Slatopolsky","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0930","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.autrev.2010.06.009","article-title":"Vitamin\u00a0D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice","volume":"9","author":"Souberbielle","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.nephro.2019.05.001_bib0935","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/archinte.168.15.1629","article-title":"25-hydroxyvitamin\u00a0D levels and the risk of mortality in the general population","volume":"168","author":"Melamed","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.nephro.2019.05.001_bib0940","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1542-4758.2010.00472.x","article-title":"Prevention of secondary hyperparathyroidism in hemodialysis patients: the key role of native vitamin\u00a0D supplementation","volume":"14","author":"Jean","year":"2010","journal-title":"Hemodial Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0945","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11255-010-9723-x","article-title":"Vitamin\u00a0D insufficiency and bone fractures in patients on maintenance hemodialysis","volume":"43","author":"Ambrus","year":"2010","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.nephro.2019.05.001_bib0950","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s00467-010-1452-y","article-title":"Vitamin\u00a0D insufficiency: implications for the immune system","volume":"25","author":"Baeke","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nephro.2019.05.001_bib0955","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.2215\/CJN.00260109","article-title":"Vitamin\u00a0D affects survival independently of vascular calcification in chronic kidney disease","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2019.05.001_bib0960","doi-asserted-by":"crossref","first-page":"c58","DOI":"10.1159\/000151534","article-title":"Evidence for persistent vitamin\u00a0D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6\u00a0months of 25-hydroxycholecalciferol treatment","volume":"110","author":"Jean","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.nephro.2019.05.001_bib0965","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1210\/jc.2004-0360","article-title":"Vitamin\u00a0D2\u00a0is much less effective than vitamin\u00a0D3\u00a0in humans","volume":"89","author":"Armas","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nephro.2019.05.001_bib0970","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1093\/ndt\/gfp370","article-title":"Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin\u00a0D supplementation","volume":"24","author":"Jean","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2019.05.001_bib0975","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/j.1523-1755.2005.00603.x","article-title":"25-hydroxyvitamin\u00a0D levels and bone histomorphometry in hemodialysis renal osteodystrophy","volume":"68","author":"Coen","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2019.05.001_bib0980","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2215\/CJN.03940510","article-title":"Vitamin\u00a0D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials","volume":"6","author":"Kandula","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2019.05.001_bib0985","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/archinternmed.2008.600","article-title":"Prevention of nonvertebral fractures with oral vitamin\u00a0D and dose dependency: a meta-analysis of randomized controlled trials","volume":"169","author":"Bischoff-Ferrari","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.nephro.2019.05.001_bib0990","first-page":"S54","article-title":"Use of oral and parenteral calcitriol in the treatment of renal osteodystrophy","volume":"29","author":"Coburn","year":"1990","journal-title":"Kidney Int"},{"issue":"5Suppl. 5","key":"10.1016\/j.nephro.2019.05.001_bib0995","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1053\/ajkd.2001.28109","article-title":"Vitamin\u00a0D analogues for the management of secondary hyperparathyroidism","volume":"38","author":"Martin","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2019.05.001_bib1000","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.nephro.2009.12.004","article-title":"Traitement de l\u2019hyperparathyro\u00efdie secondaire, r\u00e9sistante aux th\u00e9rapeutiques conventionnelles, et de l\u2019hyperparathyro\u00efdie tertiaire par le cinacalcet: une strat\u00e9gie efficace","volume":"6","author":"Jean","year":"2010","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2019.05.001_bib1005","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2019.05.001_bib1010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2215\/CJN.03591006","article-title":"study: assessing a new cinacalcet (Sensipar\/Mimpara) treatment algorithm for secondary hyperparathyroidism","volume":"3","author":"Messa","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2019.05.001_bib1015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5414\/CNP68063","article-title":"12\u00a0months cinacalcet therapy in hemodialysis patients with secondary hyperparathyroidism: effect on bone markers","volume":"68","author":"Jean","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2019.05.001_bib1020","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/ndt\/gfm172","article-title":"Six cases of successful cinacalcet cessation in haemodialysis patients treated for secondary hyperparathyroidism","volume":"22","author":"Jean","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2019.05.001_bib1025","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1359\/jbmr.2003.18.5.919","article-title":"Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin\u00a0D plus calcium, and alendronate plus calcium","volume":"18","author":"Sambrook","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.nephro.2019.05.001_bib1030","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.clinthera.2007.08.008","article-title":"A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics","volume":"29","author":"Pazianas","year":"2007","journal-title":"Clin Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.nephro.2019.05.001_bib1035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1755-6686.2009.00058.x","article-title":"Phosphate management-a dietitian's perspective","volume":"35","author":"Kariyawasam","year":"2009","journal-title":"J Ren Care"},{"issue":"Suppl. 3","key":"10.1016\/j.nephro.2019.05.001_bib1040","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/ndt\/13.suppl_3.65","article-title":"Is it possible to control hyperphosphataemia with diet, without inducing protein malnutrition?","volume":"13","author":"Rufino","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2019.05.001_bib1045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000067866","article-title":"A kinetic model of inorganic phosphorus mass balance in hemodialysis therapy","volume":"21","author":"Gotch","year":"2003","journal-title":"Blood Purif"},{"key":"10.1016\/j.nephro.2019.05.001_bib0525","first-page":"S62","article-title":"Parathyroidectomy in chronic renal failure: indications, surgical approach and the use of calcitriol","volume":"29","author":"Llach","year":"1990","journal-title":"Kidney Int"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725519301245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725519301245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2019.05.001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T14:36:41Z","timestamp":1741185401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725519301245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":105,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1769725519301245"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2019.05.001","relation":{},"ISSN":["1769-7255"],"issn-type":[{"value":"1769-7255","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complications et prises en charge th\u00e9rapeutiques des anomalies du m\u00e9tabolisme phosphocalcique de l\u2019insuffisance r\u00e9nale chronique","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2019.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 francophone de n\u00e9phrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}